STAGE III GASTRIC CANCER AJCC V7
Clinical trials for STAGE III GASTRIC CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III GASTRIC CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III GASTRIC CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets hard-to-treat stomach cancers
Disease control OngoingThis study is for people with specific types of stomach cancer (mismatch repair deficient or Epstein-Barr virus positive). It tests whether giving the immunotherapy drug pembrolizumab before and during standard chemotherapy and radiation can help prevent the cancer from coming ba…
Matched conditions: STAGE III GASTRIC CANCER AJCC V7
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New drug hopes to boost Radiation's punch against tough gut cancers
Symptom relief OngoingThis early-phase study tests an oral drug called ropidoxuridine (IPdR) in people with advanced gastrointestinal cancers that cannot be cured. The goal is to find the safest dose and see if it can make radiation therapy more effective at shrinking tumors. Nineteen participants wit…
Matched conditions: STAGE III GASTRIC CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated Jun 10, 2026 13:24 UTC